Details
- Manufacturer
- Ferring AG
- ATC code
- G03GA02
- Status
- 9 abgeschlossen
- Reported since
- 42 days
- Expected to be available
- offen
- First report
- 26.02.2026
- Reported by
- Grossist
- Active substance
- menotropinum
- Swissmedic no.
- 6802001
- Public price (PPUB)
- CHF 191.20
- Ex-factory price (PEXF)
- CHF 160.72
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
MENOPUR Multidose Inj Lös 600 IE/0.96ml Fertpen is a medication by Ferring AG containing the active substance menotropinum (ATC code G03GA02). This entry is marked as resolved — the documented shortage lasted 42 days. Shortages of this active substance in Switzerland have lasted on average 101 days (measured across 8 historical cases). Switzerland has 17 other products approved with the same active substance — none are currently available.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
menotropinum 600 U.I., arginini hydrochloridum, methioninum, polysorbatum 20, phenolum, natrii hydroxidum aut acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 0.96 ml corresp. natrium 14.2 µg.
Historical history
This product (or one with the same active substance) has already been 8× in shortage.
Frequently asked questions
What can I do if MENOPUR Multidose Inj Lös 600 IE/0.96ml Fertpen is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (menotropinum) is often possible. Available alternatives are listed above on this page.
What alternatives exist for MENOPUR Multidose Inj Lös 600 IE/0.96ml Fertpen?▾
Available alternatives with the same active substance are listed above. menotropinum is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will MENOPUR Multidose Inj Lös 600 IE/0.96ml Fertpen be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is MENOPUR Multidose Inj Lös 600 IE/0.96ml Fertpen unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of MENOPUR Multidose Inj Lös 600 IE/0.96ml Fertpen?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness